TNF and rheumatoid arthritis: Monoclonal anti-TNF α antibody (anti-TNF α Ab) linked to chondroitin sulfate (CS) modified poly(amidoamine) (CS/PAMAM) dendrimer nanoparticles (NPs) were developed and demonstrated a more targeted and effective therapeutic effect for the management of RA [25].